モダリスの株価時系列
日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
---|---|---|---|---|---|---|---|
2021/01/04 | 2,220 | 2,473 | 2,220 | 2,400 | +188 | +8.5% | 789,200 |
2020/12/30 | 2,074 | 2,215 | 2,074 | 2,212 | +88 | +4.1% | 314,100 |
2020/12/29 | 1,981 | 2,136 | 1,979 | 2,124 | +149 | +7.5% | 412,600 |
2020/12/28 | 2,016 | 2,082 | 1,975 | 1,975 | -42 | -2.1% | 317,200 |
2020/12/25 | 1,980 | 2,077 | 1,970 | 2,017 | +44 | +2.2% | 322,000 |
2020/12/24 | 1,892 | 2,035 | 1,892 | 1,973 | +75 | +4% | 548,700 |
2020/12/23 | 1,870 | 1,907 | 1,801 | 1,898 | +21 | +1.1% | 422,200 |
2020/12/22 | 1,890 | 1,938 | 1,816 | 1,877 | -14 | -0.7% | 590,700 |
2020/12/21 | 1,895 | 1,943 | 1,741 | 1,891 | -35 | -1.8% | 862,400 |
2020/12/18 | 1,815 | 2,013 | 1,814 | 1,926 | +132 | +7.4% | 1,043,600 |
2020/12/17 | 1,800 | 1,844 | 1,701 | 1,794 | -65 | -3.5% | 2,211,700 |
2020/12/16 | 1,859 | 1,859 | 1,859 | 1,859 | -500 | -21.2% | 82,400 |
2020/12/15 | 2,401 | 2,435 | 2,329 | 2,359 | -56 | -2.3% | 167,700 |
2020/12/14 | 2,348 | 2,436 | 2,319 | 2,415 | +103 | +4.5% | 258,000 |
2020/12/11 | 2,234 | 2,399 | 2,223 | 2,312 | +98 | +4.4% | 370,000 |
2020/12/10 | 2,342 | 2,350 | 2,204 | 2,214 | -145 | -6.1% | 408,000 |
2020/12/09 | 2,391 | 2,442 | 2,351 | 2,359 | -28 | -1.2% | 242,300 |
2020/12/08 | 2,350 | 2,428 | 2,331 | 2,387 | +32 | +1.4% | 252,500 |
2020/12/07 | 2,502 | 2,502 | 2,351 | 2,355 | -97 | -4% | 331,100 |
2020/12/04 | 2,440 | 2,502 | 2,430 | 2,452 | +9 | +0.4% | 257,300 |
2020/12/03 | 2,529 | 2,559 | 2,442 | 2,443 | -86 | -3.4% | 321,000 |
2020/12/02 | 2,477 | 2,575 | 2,477 | 2,529 | +43 | +1.7% | 418,500 |
2020/12/01 | 2,423 | 2,501 | 2,423 | 2,486 | -15 | -0.6% | 297,500 |
2020/11/30 | 2,469 | 2,513 | 2,430 | 2,501 | +68 | +2.8% | 531,300 |
2020/11/27 | 2,418 | 2,433 | 2,362 | 2,433 | +15 | +0.6% | 245,800 |
2020/11/26 | 2,362 | 2,424 | 2,352 | 2,418 | +51 | +2.2% | 252,800 |
2020/11/25 | 2,434 | 2,482 | 2,350 | 2,367 | -69 | -2.8% | 376,300 |
2020/11/24 | 2,430 | 2,475 | 2,420 | 2,436 | +7 | +0.3% | 220,100 |
2020/11/20 | 2,425 | 2,444 | 2,368 | 2,429 | +1 | ±0% | 192,000 |
2020/11/19 | 2,406 | 2,435 | 2,395 | 2,428 | -24 | -1% | 182,100 |
2020/11/18 | 2,470 | 2,515 | 2,430 | 2,452 | -13 | -0.5% | 203,100 |
2020/11/17 | 2,533 | 2,578 | 2,450 | 2,465 | -108 | -4.2% | 299,500 |
2020/11/16 | 2,500 | 2,587 | 2,470 | 2,573 | +71 | +2.8% | 279,900 |
2020/11/13 | 2,461 | 2,534 | 2,426 | 2,502 | +69 | +2.8% | 339,700 |
2020/11/12 | 2,550 | 2,554 | 2,419 | 2,433 | -114 | -4.5% | 495,300 |
2020/11/11 | 2,470 | 2,595 | 2,460 | 2,547 | +77 | +3.1% | 338,700 |
2020/11/10 | 2,550 | 2,589 | 2,470 | 2,470 | -130 | -5% | 379,100 |
2020/11/09 | 2,600 | 2,616 | 2,515 | 2,600 | +32 | +1.2% | 455,200 |
2020/11/06 | 2,700 | 2,720 | 2,496 | 2,568 | -281 | -9.9% | 1,478,900 |
2020/11/05 | 2,715 | 2,864 | 2,673 | 2,849 | +205 | +7.8% | 707,100 |
2020/11/04 | 2,640 | 2,684 | 2,568 | 2,644 | +36 | +1.4% | 351,800 |
2020/11/02 | 2,580 | 2,662 | 2,503 | 2,608 | +106 | +4.2% | 447,400 |
2020/10/30 | 2,579 | 2,595 | 2,460 | 2,502 | +7 | +0.3% | 424,200 |
2020/10/29 | 2,301 | 2,560 | 2,300 | 2,495 | +112 | +4.7% | 500,400 |
2020/10/28 | 2,456 | 2,518 | 2,373 | 2,383 | -82 | -3.3% | 256,500 |
2020/10/27 | 2,300 | 2,472 | 2,290 | 2,465 | +20 | +0.8% | 528,000 |
2020/10/26 | 2,650 | 2,664 | 2,424 | 2,445 | -205 | -7.7% | 564,600 |
2020/10/23 | 2,705 | 2,719 | 2,571 | 2,650 | -45 | -1.7% | 414,600 |
2020/10/22 | 2,743 | 2,823 | 2,671 | 2,695 | -78 | -2.8% | 429,800 |
2020/10/21 | 2,685 | 2,840 | 2,683 | 2,773 | +82 | +3% | 375,800 |
1151~
1200
件表示中 / 1254件
類似銘柄と比較する
現在ご覧いただいている「モダリス」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
---|---|---|---|---|---|---|---|---|
モダリス | 8,000円 | - | - | 0.00% | - | 1.95倍 |
|
遺伝子治療薬の創薬ベンチャー、DNA切断しないエピゲノム編集に強み。研究開発中心は米国 |
日ケミファ | 157,500円 | +7.5% | -77.4% | 3.17% | 37.88倍 | 0.30倍 |
|
後発薬中堅、検査薬事業が第2の柱に。提携含めた新薬開発、ベトナムなど海外事業を中期強化 |
PRISMBio | 17,100円 | +14.8% | - | 0.00% | - | 2.06倍 |
|
独自の創薬基盤技術で細胞内タンパク質間相互作用制御する低分子化合物の創薬ベンチャー |
DELTA-P | 52,900円 | - | - | 0.00% | - | 22.17倍 |
|
創薬ベンチャー。既存の抗がん物質を組み合わせて安全性と有効性を高めた抗がん剤を開発 |
カイノス | 127,500円 | +3.7% | +2.7% | 2.51% | 8.96倍 | 0.79倍 |
|
臨床検査薬の中堅メーカー。生化学、免疫血清学的検査用試薬に重点。共同開発の促進に注力 |
市場注目の銘柄
チャート関連のコラム